Category Lobbying

WHO Board Debates Framework On Engagement With Non-State Actors

The World Health Organization routinely works with a number of outside actors, such as non-governmental groups, philanthropic organisations, industry and academics. Member states have been trying to establish a framework to regulate such engagement and are still working to produce a consensus document. This week they are trying to extend the mandate of an intergovernmental meeting in the hope that an ultimate meeting in April can solve remaining issues.

WHO Board To Address Reform Progress, R&D Financing, Lobbyists/ Foundations

Next week, the World Health Organization Executive Board will hold its biannual meeting. On the agenda are key subjects such as the WHO reform process, sharing of influenza viruses for R&D, and a controversial framework for the WHO’s engagement with actors such as non-governmental organisations, private entities, and foundations. Also on the agenda is the effort to address the growing microbial resistance to antibiotics, and finding a way to finance research and development for diseases affecting primarily developing countries.

Obama Calls For TPP Approval On Eve Of ITC Hearing

On the eve of a three-day mega hearing on the impact of the Trans-Pacific Partnership (TPP) starting today at the US International Trade Commission, President Barack Obama called on Congress to approve the trade deal. In his final annual State of the Union Address last night, the TPP got only a minor mention.

New Year Brings New Faces To IP World, Bids Others Farewell

The New Year brings some new faces in the intellectual property world as several changes were announced at the end of 2015, in particular at the European Commission, in the private sector and non-governmental organisations. In Geneva, the coordination of the Group of Latin American and Caribbean countries changes, and the UN Plant Treaty is working on intersessional committees. And a leading light in the IP publishing world has retired.

University Students Energise Global Campaign For Medical R&D Agreement

The force of hundreds of students worldwide has gathered behind an international effort urging governments to promote research and development in a way that does not result in high-priced medicines. The initiative led by Universities Allied for Essential Medicines (UAEM) seeks to address the longstanding gap in affordable medicines and puts the focus on the World Health Organization, whose members are currently working on this issue.